Clinical Trial Update: Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of fenofibrate on endothelial progenitor cells in patients with diabetes and diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Diabetic Retinopathy

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: University of Padova | Conditions: Diabetes, Diabetic Retinopathy | Phase 4 | Status: COMPLETED